Relative abundance of a gut-derived Lancefieldella parvula strain is associated with severe inflammation in IBD
5 affiliations
- 1School of Pharmaceutical Sciences, Faculty of Medicine, University of Ottawa, Ottawa, ON Canada
- 2Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON Canada
- 3Department of Pediatrics, Faculty of Medicine, University of Ottawa, Ottawa, K1H 8M5 ON Canada
- 4Inflammatory Bowel Disease Centre and CHEO Research Institute, Children’s Hospital of Eastern Ontario, Ottawa, K1H 8L1 ON Canada
- 5Université de Strasbourg, CNRS, IPHC UMR7178, Strasbourg, France
Abstract
Background: Lancefieldella parvula (previously known as Atopobium parvulum) has been associated with inflammatory bowel disease (IBD); however, prior in vivo studies relied on an oral-derived reference strain rather than intestinal clinical isolates, limiting interpretation of its role in gut inflammation. To address this gap, we isolated a clinical strain of L. parvula (designated L. parvula TI19E08) from a mucosal luminal aspirate of an ulcerative colitis (UC) participant. We developed a strain-specific quantitative PCR assay to quantify its abundance across anatomical sites in treatment-naïve pediatric IBD participant (UC and Crohn’s disease (CD)) and examined its relationship with site-specific endoscopic inflammation severity.
Results: We demonstrated that the relative abundance of L. parvula TI19E08 increased with increasing local inflammation severity. In UC, both strain-specific and total L. parvula levels were strongly correlated with inflammation severity, particularly in the proximal colon. In CD patients, strain-level associations were most pronounced in the terminal ileum, which is consistent with the disease distribution.
Conclusion: This study characterizes an intestinal L. parvula isolate and demonstrates that strain-level expansion correlates with disease severity across IBD subtypes and anatomical regions. These findings identify L. parvula TI19E08 as a candidate mucosal marker of inflammation severity in IBD patients.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s13099-026-00865-x.
Related
- Mesenchymal stromal cell-derived extracellular vesicles attenuate inflammation-associated cognitive impairment and hippocampal microglial-synaptic remodeling
- Routine CBC-Derived Markers of Systemic Inflammation Are Associated With Growth of the Dilated Ascending Aorta During CT Surveillance
- Uterine-cavity Lactobacillus relative abundance and endometrial polyp recurrence after hysteroscopic polypectomy: a retrospective cohort study.
- FDX1 is associated with CALR abundance and JAK–STAT-related inflammatory signaling in myeloproliferative neoplasms
- Isocaloric restriction normalizes body weight but not relative adiposity, adipose inflammation, or gut microbial diversity in high-fat diet-fed mice
BibTeX
@article{weerasingha2026relative,
title = {{Relative abundance of a gut-derived Lancefieldella parvula strain is associated with severe inflammation in IBD}},
author = {Sasanka Weerasingha and Austin Yan and James Butcher and David R. Mack and Alain Stintzi},
journal = {Gut Pathogens},
year = {2026},
month = aug,
doi = {10.1186/s13099-026-00865-x},
url = {https://doi.org/10.1186/s13099-026-00865-x},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Relative abundance of a gut-derived Lancefieldella parvula strain is associated with severe inflammation in IBD
AU - Sasanka Weerasingha
AU - Austin Yan
AU - James Butcher
AU - David R. Mack
AU - Alain Stintzi
PY - 2026
DA - 2026/08/14
JO - Gut Pathogens
DO - 10.1186/s13099-026-00865-x
UR - https://doi.org/10.1186/s13099-026-00865-x
AB - Background: Lancefieldella parvula (previously known as Atopobium parvulum) has been associated with inflammatory bowel disease (IBD); however, prior in vivo studies relied on an oral-derived reference strain rather than intestinal clinical isolates, limiting interpretation of its role in gut inflammation. To address this gap, we isolated a clinical strain of L. parvula (designated L. parvula TI19E08) from a mucosal luminal aspirate of an ulcerative colitis (UC) participant. We developed a strain-specific quantitative PCR assay to quantify its abundance across anatomical sites in treatment-naïve pediatric IBD participant (UC and Crohn’s disease (CD)) and examined its relationship with site-specific endoscopic inflammation severity. Results: We demonstrated that the relative abundance of L. parvula TI19E08 increased with increasing local inflammation severity. In UC, both strain-specific and total L. parvula levels were strongly correlated with inflammation severity, particularly in the proximal colon. In CD patients, strain-level associations were most pronounced in the terminal ileum, which is consistent with the disease distribution. Conclusion: This study characterizes an intestinal L. parvula isolate and demonstrates that strain-level expansion correlates with disease severity across IBD subtypes and anatomical regions. These findings identify L. parvula TI19E08 as a candidate mucosal marker of inflammation severity in IBD patients. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s13099-026-00865-x.
SN - 1757-4749
ER -